DANIEL PERRY: Open Payments
NPI 1912429069 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 41 payments from 11 companies in 2025. Trend: 2023 $71 · 2024 $91 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $261 |
| Alkermes, Inc. | 8 | $211 |
| Axsome Therapeutics, Inc. | 4 | $207 |
| Vanda Pharmaceuticals Inc. | 6 | $207 |
| Otsuka America Pharmaceutical, Inc. | 3 | $157 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| ABBVIE INC. | 5 | $110 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Bausch Health US, LLC | 1 | $25 |
Products named: ARISTADA, Auvelity, FANAPT, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, VRAYLAR, SPRAVATO.
Industry payments across GA — which companies pay providers there.
